Fig. 1From: The utility of apoptosis inhibitor of macrophages as a possible diagnostic marker in patients with Crohn’s diseaseComparison of serum AIM levels in patients with Crohn’s disease (CD), ulcerative colitis (UC), intestinal Behcet’s disease (BD), and healthy volunteers (HV). Serum AIM levels in the patients with CD were significantly higher than those in the other groupsBack to article page